• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:刘泰,曾佩佩,张青萍.养血清脑颗粒治疗血管性认知功能障碍疗效的Meta分析[J].药学研究,2016,35(1):49-52[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 4664次   下载 3994次 本文二维码信息
码上扫一扫!
养血清脑颗粒治疗血管性认知功能障碍疗效的Meta分析
刘泰,曾佩佩,张青萍
字体:加大+|默认|缩小-
(广西中医药大学第一附属医院,广西 南宁 530023)
摘要:
目的 评价养血清脑颗粒治疗血管性认知功能障碍的疗效。方法 通过计算机检索工具检索、手工检索,全面搜集养血清脑颗粒治疗血管性认知功能障碍的随机对照实验,按Cochrane协作网发布的RevMan 5.2软件对多个研究结果的总体效应进行Meta分析。结果 共纳入8个实验(579例患者),其中8个实验均对MMSE进行评分,显示养血清脑颗粒提高MMSE评分优于对照组[WMD=2.47,95%CI(1.57,3.37)];4个实验对患者HDS进行评分,提示养血清脑颗粒提高HDS评分优于对照组[WMD=4.80,95%CI(3.94,5.67)];4个实验对患者ADL进行评分,显示养血清脑颗粒提高ADL评分优于对照组[WMD=-4.43,95%CI(-5.75,-3.12)];4个实验对患者有效率进行评定,提示养血清脑颗粒的疗效优于对照组[OR=2.87,95%CI(1.67,4.94)];结论 养血清脑颗粒治疗血管性认知功能障碍有效。
关键词:  养血清脑颗粒  血管性认知功能障碍  血管性痴呆  Meta分析
DOI:
基金项目:广西医疗卫生适宜技术研究与开发课题(No.S201410-01)
Meta analysis of Yangxueqingnao Granule in the treatment of vascular cognitive dysfunction
LIU Tai,ZENG Peipei,ZHANG Qingping
(The First Affiliated Hospital of Guangxi traditional Chinese Medicine University,Nanning 530023,China)
Abstract:
Objective To evaluate the therapeutic effect of Yangxue Qingnao Granule on vascular cognitive impairment.Methods The randomized controlled trials of Yangxue Qingnao Granule in treating vascular cognitive impairment was collected by computer retrieval tools and manual retrieval,extract data and Meta-analysis was analyzed with Revman 5.2 software released by Cochrane.Results 8 experiments were included (579 patients),all experiments were carried out on the MMSE score,results displayed that Yangxue Qingnao Granule improving MMSE scores was better than the control group [WMD=2.47,95%CI (1.57,3.37)];4 experiments were carried out on the HDS scores,which displayed that Yangxue Qingnao Granule improving HDS was better than the control group [WMD=4.80,95%CI(3.94,5.67)];4 experimental were carried out on the HDL scores,results displayed that Yangxue Qingnao Granule improving ADL scores was better than the control group [WMD=-4.43,95%CI (-5.75,-3.12)];4 experimental was evaluated on efficiency, which indicated that the effect of Yangxue Qingnao granule was better than the control group [OR=2.87, 95%CI (1.67,4.94)];Conclusion Yangxue Qingnao Granule was efficacious on treating vascular cognitive impairment.
Key words:  Yangxue Qingnao Granule  Vascular cognitive impairment  Vascular dementia  Meta analysis
今日访问量:2263    总访问量:55338602
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司